Advances in detection methods including magnetic resonance imaging and prostate specific antigen (PSA) screening [22, 23] helped detection of prostate cancer at earlier stages and designing effective therapeutic strategies, such as surgical or radiation therapies or in some cases active surveillance [24, 25]. This evidence concerns the gene KLK3 and prostate carcinoma.